Spectrum Pharmaceuticals (SPPI) PT Lowered to $42 at H.C. Wainwright

March 1, 2019 9:02 AM EST Send to a Friend
H.C. Wainwright analyst Edward White lowered the price target on Spectrum Pharmaceuticals (NASDAQ: SPPI) to $42.00 (from $43.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login